NCT01224756View on ClinicalTrials.gov

Efficacy of Tinoridine in Treating Pain and Inflammation in Adults

PHASE4CompletedINTERVENTIONAL
Enrollment

342

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2011

Conditions
PainInflammation
Interventions
DRUG

Tinoridine HCl

Tinoridine HCl 50 mg, orally, 2 capsules three times daily for up to 4 days.

DRUG

Placebo

Tinoridine placebo-matching capsules, orally, 2 capsules three times daily for up to 4 days.

Trial Locations (4)

Unknown

Semarang

Jakarta

Surabaya

Bandung

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY